Verona Pharma plc (VRNA)
69/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $72.7B
- P/E
- —
- Sector Median P/E
- 24.9
- F-Score
- 4/9
- ROIC
- 1.9%
- FCF Yield
- -0.1%
With a Tessera Quality Score of 68, VRNA ranks in the top 50% of Healthcare stocks tracked. Piotroski F-Score is 4/9; trailing ROIC is 1.9%.
Sector Peers
- Vertex Pharmaceuticals Incorporated (VRTX)Mkt Cap: $134.0B · FCF: 30.3%
- Regeneron Pharmaceuticals, Inc. (REGN)Mkt Cap: $68.3B · FCF: 27.9%
- argenx SE (ARGX)Mkt Cap: $54.8B · FCF: 12.0%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%
- Alnylam Pharmaceuticals, Inc. (ALNY)Mkt Cap: $41.5B · FCF: 15.0%